Medicaid Prior Authorization Policy for Buprenorphine-Containing Products for Medication-Assisted Treatment

Wisconsin Stat. § 49.45(29z)

Buprenorphine prior authorization review. The department shall review its prior authorization policy on buprenorphine-containing products provided to Medical Assistance program recipients. On the first day of the 7th month beginning after the effective date of this subsection .... [LRB inserts date], and every 6 months thereafter, the department shall submit to the standing committees of the legislature with jurisdiction over health under s. 13.172 (3) a report describing the department's findings on the prior authorization policy on buprenorphine-containing products and its progress on eliminating prior authorization requirements for buprenorphine-containing products in populations where removal of prior authorization is appropriate.

Assigned Number Titlesort descending Version Date Publication Type Other Location Language
P-02294 Medicaid Prior Authorization Policy for Buprenorphine-Containing Products for Medication-Assisted Treatment December 13, 2018
PDF
English
P-02294 Medicaid Prior Authorization Policy for Buprenorphine-Containing Products for Medication-Assisted Treatment, June 2019 July 10, 2019
PDF
English
Last Revised: July 10, 2019